Inhibitor Therapeutics INTI
OTC INTI
$0.09 -0.02 (-18.18%)
At close: Oct 21, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Net Debt Issuances and Repayments (2013 - 2023)

Updated

Analysis

Inhibitor Therapeutics (INTI) Net Debt Issuances and Repayments (2013 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -2.00 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 64.00 Mn
10 Inhibitor Therapeutics 15.64 Mn 8.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -411,000.00
Sep 30, 2022 80,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 50,000.00
Jun 30, 2021 75,000.00
Mar 31, 2021 101,000.00
Dec 31, 2020 55,000.00
Jun 30, 2020 41,600.00
Jun 30, 2014 164,894.00
Mar 31, 2014 108,744.00
Dec 31, 2013 169,542.00
Sep 30, 2013 127,324.00
API Access

Inhibitor Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=INTI&period=max&api_key=YOUR_API_KEY